High hepatic and extrahepatic mortality and low treatment uptake in HCV-coinfected persons in the Swiss HIV cohort study between 2001 and 2013

Journal of Hepatology

Volumn 63, Issue 3, 2015, Pages 573-580

  Kovari, Helen ^a   Ledergerber, Bruno ^a   Cavassini, Matthias ^b   Ambrosioni, Juan ^c   Bregenzer, Andrea ^d   Stöckle, Marcel ^e   Bernasconi, Enos ^f   Kouyos, Roger ^a,g   Weber, Rainer ^a   Rauch, Andri ^h  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c UNIVERSITY HOSPITAL   (Switzerland)

^d CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^e UNIVERSITY HOSPITAL BASEL   (Switzerland)

^f REGIONAL HOSPITAL OF LUGANO   (Switzerland)

^g UNIVERSITY OF ZURICH   (Switzerland)

^h UNIVERSITY OF BERN   (Switzerland)

Author keywords

Epidemiology; HCV; HIV; Mortality; Treatment

Indexed keywords

PEGINTERFERON; RIBAVIRIN; VIRUS RNA;

ADOLESCENT; ADULT; ANTIVIRAL THERAPY; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; DRUG TREATMENT FAILURE; FEMALE; FOLLOW UP; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORTALITY; PRIORITY JOURNAL; SURVIVAL; SWISS; TREATMENT OUTCOME; VIRUS REPLICATION; MIDDLE AGED; PROSPECTIVE STUDY; TIME FACTOR;

ADOLESCENT; ADULT; COHORT STUDIES; COINFECTION; FEMALE; HEPATITIS C; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RNA, VIRAL; TIME FACTORS;

EID: 84983161193     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2015.04.019     Document Type: Article

References (27)

1. H.J. Alter, and T.J. Liang Hepatitis C: the end of the beginning and possibly the beginning of the end Ann Intern Med 156 2012 317 318
2. R.T. Chung, J. Andersen, P. Volberding, G.K. Robbins, T. Liu, K.E. Sherman, and et al. Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons N Engl J Med 351 2004 451 459
3. F.J. Torriani, M. Rodriguez-Torres, J.K. Rockstroh, E. Lissen, J. Gonzalez-Garcia, A. Lazzarin, and et al. Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients N Engl J Med 351 2004 438 450
4. F. Carrat, F. Bani-Sadr, S. Pol, E. Rosenthal, F. Lunel-Fabiani, A. Benzekri, and et al. Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial JAMA 292 2004 2839 2848
5. L.I. Backus, D.B. Boothroyd, B.R. Phillips, P. Belperio, J. Halloran, and L.A. Mole A sustained virologic response reduces risk of all-cause mortality in patients with hepatitis C Clin Gastroenterol Hepatol 9 2011 e501
6. B.N. Limketkai, S.H. Mehta, C.G. Sutcliffe, Y.M. Higgins, M.S. Torbenson, S.C. Brinkley, and et al. Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV JAMA 308 2012 370 378
7. C.U. Oramasionwu, H.N. Moore, and J.C. Toliver Barriers to hepatitis C antiviral therapy in HIV/HCV co-infected patients in the United States: a review AIDS Patient Care STDS 28 2014 228 239
8. B. Ledergerber, J. von Overbeck, M. Egger, and R. Luthy The Swiss HIV Cohort Study: rationale, organization and selected baseline characteristics Soz Praventivmed 39 1994 387 394
9. Swiss HIVCS F. Schoeni-Affolter, B. Ledergerber, M. Rickenbach, C. Rudin, H.F. Gunthard, and et al. Cohort profile: the Swiss HIV Cohort study Int J Epidemiol 39 2010 1179 1189
10. Lundgren J.D. RJ. European AIDS Clinical Society (EACS) Guidelines 7.0, October 2013. European AIDS Clinical Society (EACS), 2013.
11. European Association for Study of Liver EASL Clinical Practice Guidelines: management of hepatitis C virus infection J Hepatol 60 2014 392 420
12. P. Bedossa, and T. Poynard An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group Hepatology 24 1996 289 293
13. L. Castera, X. Forns, and A. Alberti Non-invasive evaluation of liver fibrosis using transient elastography J Hepatol 48 2008 835 847
14. R.K. Sterling, E. Lissen, N. Clumeck, R. Sola, M.C. Correa, J. Montaner, and et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection Hepatology 43 2006 1317 1325
15. C.T. Wai, J.K. Greenson, R.J. Fontana, J.D. Kalbfleisch, J.A. Marrero, H.S. Conjeevaram, and et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C Hepatology 38 2003 518 526
16. D. Grint, L. Peters, C. Schwarze-Zander, M. Beniowski, C. Pradier, M. Battegay, and et al. Temporal changes and regional differences in treatment uptake of hepatitis C therapy in EuroSIDA HIV Med 14 2013 614 623
17. C. Beisel, M. Heuer, B. Otto, J. Jochum, S. Schmiedel, S. Hertling, and et al. German cohort of HCV mono-infected and HCV/HIV co-infected patients reveals relative under-treatment of co-infected patients AIDS Res Ther 11 2014 16
18. J. Stenkvist, O. Weiland, A. Sonnerborg, A. Blaxhult, and K. Falconer High HCV treatment uptake in the Swedish HIV/HCV co-infected cohort Scand J Infect Dis 46 2014 624 632
19. J.R. Kramer, F. Kanwal, P. Richardson, M. Mei, and H.B. El-Serag Gaps in the achievement of effectiveness of HCV treatment in national VA practice J Hepatol 56 2012 320 325
20. S. Erqou, A. Mohanty, P. Murtaza Kasi, and A.A. Butt Predictors of mortality among United States veterans with human immunodeficiency virus and hepatitis C virus coinfection ISRN Gastroenterol 2014 2014 764540
21. J. Grebely, J.D. Raffa, C. Lai, M. Krajden, T. Kerr, B. Fischer, and et al. Low uptake of treatment for hepatitis C virus infection in a large community-based study of inner city residents J Viral Hepat 16 2009 352 358
22. A. Rauch, Z. Kutalik, P. Descombes, T. Cai, J. Di Iulio, T. Mueller, and et al. Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study Gastroenterology 138 2010 1338 1345 1345, e1331-e1337
23. R. Mahajan, J. Xing, S.J. Liu, K.N. Ly, A.C. Moorman, L. Rupp, and et al. Mortality among persons in care with hepatitis C virus infection: the Chronic Hepatitis Cohort Study (CHeCS), 2006-2010 Clin Infect Dis 58 2014 1055 1061
24. J. Berenguer, E. Rodriguez, P. Miralles, M.A. Von Wichmann, J. Lopez-Aldeguer, J. Mallolas, and et al. Sustained virological response to interferon plus ribavirin reduces non-liver-related mortality in patients coinfected with HIV and Hepatitis C virus Clin Infect Dis 55 2012 728 736
25. J. Berenguer, F.X. Zamora, A. Carrero, M.A. Von Wichmann, M. Crespo, J. Lopez-Aldeguer, and et al. Effects of sustained viral response in patients with HIV and chronic hepatitis C and nonadvanced liver fibrosis J Acquir Immune Defic Syndr 66 2014 280 287
26. J. Pinchoff, A. Drobnik, K. Bornschlegel, S. Braunstein, C. Chan, J.K. Varma, and et al. Deaths among people with hepatitis C in New York City, 2000-2011 Clin Infect Dis 58 2014 1047 1054
27. G. Wandeler, T. Gsponer, A. Bregenzer, H.F. Gunthard, O. Clerc, A. Calmy, and et al. Hepatitis C virus infections in the Swiss HIV Cohort Study: a rapidly evolving epidemic Clin Infect Dis 55 2012 1408 1416